Home
About
FAQ
History (11)
Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis.
Differences in psoriasis signs and symptom severity between patients with clear and almost clear skin in clinical practice.
Top dermatologic conditions in patients of color: an analysis of nationally representative data.
Short-term outcomes of robotically assisted patello-femoral arthroplasty.
Should patients stop their biologic treatment during the COVID-19 pandemic.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Should patients stop their biologic treatment during the COVID-19 pandemic.
Bashyam AM, Feldman SR. Should patients stop their biologic treatment during the COVID-19 pandemic. J Dermatolog Treat. 2020 06; 31(4):317-318.
View in:
PubMed
subject areas
Biological Products
Coronavirus Infections
Humans
Pneumonia, Viral
Psoriasis
authors with profiles
Steven R. Feldman MD, PhD